Insights On Outsourced Drug Development

  1. Employ An icIEF-UV/MS Workflow For The Reproducible Separation Of NISTmAb Variants 8/15/2023

    Review data that supports the reproducibility of a streamlined icIEF-UV/MS workflow for charge variant separation, UV quantitation, and peak identification of monoclonal antibodies (mAbs) by coupling two systems.

  2. Precision Medicine: Going Digital To Drive Innovation 6/2/2023

    The Precision Medicine Initiative is driving forward the potential for a more customized health care approach, transforming the way health care professionals are treating diseases.

  3. Extractables And Leachables Assessment For Single-Use Systems 4/14/2025

    Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.

  4. Thermal Analysis In The Pharmaceutical Industry 12/30/2024

    Thermal analysis techniques provide valuable insights into pharmaceutical material properties, ensuring compatibility, stability, and quality control in drug development and production processes.

  5. Propelling Glioblastoma Research: Orthotopic Model Solutions 3/27/2025

    Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

  6. Mitigating Early Development Risks 9/11/2024

    Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.

  7. Combining Single-Cell Isolation And Microplate Imaging To Improve Cloning Efficiency 8/21/2023

    Improve your cloning efficiency with higher assurance of clonality by using a combination of single-cell isolation and microplate imaging.

  8. Getting Genomic Medicines Ready For Prime Time 2/5/2024

    Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.

  9. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

    Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

  10. Beyond SOPs: Assessing Quality Of CDMOs 5/16/2024

    When choosing a CDMO partner, it is essential to prioritize quality. Discover how the right partner can instill confidence in the safety and effectiveness of your pharmaceutical products.